AI Tool Reveals MS Drug Interactions, Offers Safer Options

Clinicians prescribing a drug for patients with multiple sclerosis who are on multiple treatments may in future use AI to identify potential interactions and suggest safer options, new data suggest.

Related Keywords

Milan ,Lombardia ,Italy ,Germany ,German ,Pavan Bhargava ,Michael Hecker ,European Committee For Treatment ,Rostock University Medical Center ,Research In Multiple Sclerosis ,Johns Hopkins Precision Medicine Center ,Department Of Neurology ,Americas Committee For Treatment ,Joint European Committee ,Multiple Sclerosis Americas Committee ,Multiple Sclerosis ,Medscape Medical News ,Multiple Sclerosis Ms ,Us ,Drug Interactions ,Relapsing Remitting Multiple Sclerosis ,Arms ,Ultiple Sclerosis Relapsing Remitting ,Artificial Intelligence ,A I ,Hi ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Biologic Therapy ,Adverse Effects ,Side Effects ,Europe ,European ,Patient Safety ,Tyrosine Kinase Inhibito ,